Moreover, mice studies have shown a promise in PITX2-guided pharmacotherapy, as it was indicated that flecainide was superior to sotalol in suppressing AF, explained by PITX2-mRNA modulation of atrial membrane resting potential (37). This evidence concerns the gene PITX2 and atrial fibrillation.